Bortolot, M.; Torresan, S.; De Carlo, E.; Bertoli, E.; Stanzione, B.; Del Conte, A.; Spina, M.; Bearz, A.
Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming Resistance. Int. J. Mol. Sci. 2024, 25, 12972.
https://doi.org/10.3390/ijms252312972
AMA Style
Bortolot M, Torresan S, De Carlo E, Bertoli E, Stanzione B, Del Conte A, Spina M, Bearz A.
Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming Resistance. International Journal of Molecular Sciences. 2024; 25(23):12972.
https://doi.org/10.3390/ijms252312972
Chicago/Turabian Style
Bortolot, Martina, Sara Torresan, Elisa De Carlo, Elisa Bertoli, Brigida Stanzione, Alessandro Del Conte, Michele Spina, and Alessandra Bearz.
2024. "Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming Resistance" International Journal of Molecular Sciences 25, no. 23: 12972.
https://doi.org/10.3390/ijms252312972
APA Style
Bortolot, M., Torresan, S., De Carlo, E., Bertoli, E., Stanzione, B., Del Conte, A., Spina, M., & Bearz, A.
(2024). Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming Resistance. International Journal of Molecular Sciences, 25(23), 12972.
https://doi.org/10.3390/ijms252312972
